Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cameron Dell"'
Autor:
Ahmet Dogan, Mehmet Hakan Kocoglu, Sunita Philip, Ning Ma, Olga Goloubeva, Elizabeth Hyjek, Cameron Dell, Alexander M. Lesokhin, Aaron P. Rapoport, Emily Lederer, Ashraf Z. Badros, Zeba N. Singh, Todd Milliron
Publikováno v:
Blood. 130:1189-1197
Programmed death 1 (PD-1) receptor and its ligand (PD-L1) facilitate immune evasion in multiple myeloma (MM). We hypothesized that pembrolizumab, PD-1-antibody, can enhance antimyeloma cellular immunity generated by pomalidomide, leading to improved
Autor:
Cameron Dell, Stacy Y. Chu, Carl D. Langefeld, David Y. Hwang, Mario L. Perez, Mary J. Sparks, Michael L. James, Kevin N. Sheth, Sebastian Koch, Daniel Woo, Thomas W.K. Battey, Jonathan Rosand, Mary E. Comeau, Jennifer Osborne, Steven J. Kittner, Jessica McFarlin, Tiffany D. Watson
Publikováno v:
Neurocritical Care. 27:316-325
The early subjective clinical judgment of clinicians outperforms formal prognostic scales for accurate determination of outcome after intracerebral hemorrhage (ICH), with the judgment of physicians and nurses having equivalent accuracy. This study as
Autor:
Mary J. Sparks, Kevin N. Sheth, Tiffany D. Watson, Thomas W.K. Battey, Mary E. Comeau, Jennifer Osborne, Carl D. Langefeld, Mario L. Perez, Cameron Dell, Daniel Woo, Sebastian Koch, Jonathan Rosand, Michael L. James, Steven J. Kittner, Jessica McFarlin, David Y. Hwang
Publikováno v:
Neurology. 86(2)
Objective: To compare the performance of formal prognostic instruments vs subjective clinical judgment with regards to predicting functional outcome in patients with spontaneous intracerebral hemorrhage (ICH). Methods: This prospective observational
Autor:
Sunita Philip, Ning Ma, Patricia Lesho, Ashlee Johnson, Olga Goloubeva, Mehmet H. Kocoglu, Elizabeth Hyjek, Alexander M. Lesokhin, Aaron P. Rapoport, Cameron Dell, Emily Lederer, Zeba N. Singh, Ashraf Badros
Publikováno v:
Blood. 128:490-490
BACKGROUND: Immunotherapy in MM is emerging as an effective modality in therapy of MM with the approval of several monoclonal antibodies and encouraging results for vaccines and T cell therapy. Programmed death 1 (PD-1) receptor and its ligand (PD-L1
Autor:
Sunita Philip, Mehmet H. Kocoglu, Zeba N. Singh, Emily Lederer, Cameron Dell, Nancy M. Hardy, Jean A. Yared, Olga Goloubeva, Aaron P. Rapoport, Ning Ma, Patricia Lesho, Ashraf Badros
Publikováno v:
Blood. 126:506-506
BACKGROUND: Several recent studies have linked the interactions of programmed death 1 (PD-1) receptor and its ligand (PD-L1) to immunologic control of MM. Expression of PD-L1 on myeloma cells and the abundance of PD-1 on various bone marrow microenvi